FDA Inspection 904067 — Metropolitan Reproductive Medicine, P.C.

Metropolitan Reproductive Medicine, P.C. — FEI 3006721953

The FDA completed an inspection of Metropolitan Reproductive Medicine, P.C. on November 25, 2014 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 25, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1224021 CFR 1271.55(b)(3)Name and address on summary
1224621 CFR 1271.55(d)(1)(iii)Documentation--determination, by whom, date